Jorn Drappa - Feb 18, 2025 Form 4 Insider Report for ALUMIS INC. (ALMS)

Role
Chief Medical Officer
Signature
/s/ Sara Klein, Attorney-in-Fact
Stock symbol
ALMS
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
4
Date filed
2/20/2025, 06:30 PM
Previous filing
Jun 27, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALMS Stock Option (Right to Buy) Award $0 +180K $0.00 180K Feb 18, 2025 Common Stock 180K $5.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on February 18, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.